Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics/pharmacodynamics of MK-8150 in hypertension and isolated systolic hypertension; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Isolated Systolic Hypertension

Drugs mentioned

• MK-8150 (MK-8150)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension, Isolated Systolic Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2016-04-29